Efalizumab: all 34 studies that test it
Page 1 of 1. Open to participants first (0), then studies with results posted, then the rest; newest registration first within each.
- Raptiva in Palm and Sole PsoriasisTerminatedNCT00972543Phase 4Results posted
- Raptiva and Sirolimus in Islet Transplantation for Type 1 DiabetesTerminatedNCT00672204Phase 1/2Results posted
- A Study to Evaluate the Safety and Efficacy of Efalizumab in Adult Patients With Moderate to Severe Plaque Psoriasis With Involvement of the ScalpCompletedNCT00669214Phase 4Results posted
- Efalizumab in Treating Patients With Graft-Versus-Host Disease of the Skin That Did Not Respond to Previous SteroidsTerminatedNCT00489216Not applicableResults posted
- Early Conversion From Tacrolimus to Efalizumab Maintenance Therapy in Kidney Transplant RecipientsTerminatedNCT00472082Phase 1/2Results posted
- Pilot Study of Raptiva to Treat Sjogren's SyndromeTerminatedNCT00344448Phase 2Results posted
- A Study to Evaluate Raptiva in Subjects With Chronic Moderate or Worse Plaque Psoriasis Who Have Had an Inadequate Response to an Anti-TNF AgentCompletedNCT00336973Phase 4Results posted
- A Multicentre, Open Label Phase IIIb/IV Study of Subcutaneously Administered Raptiva in the Treatment of Adult Subjects With Moderate to Severe Plaque PsoriasisCompletedNCT00287118Phase 4Results posted
- Efalizumab to Treat UveitisCompletedNCT00280826Phase 1Results posted
- Study of the Drug Efalizumab (Raptiva), for Adult Patients With Moderate to Severe Plaque PsoriasisCompletedNCT00115076Phase 3Results posted
- Pilot Trial to Assess Effect of CNI Conversion of Efalizumab on T Reg CellsWithdrawnNCT00777400Phase 1/2
- Efalizumab in the Treatment of Alopecia, Phase IIWithdrawnNCT00746980Phase 2
- Beta Cell Rescue in New Onset Type 1 Diabetes With EfalizumabWithdrawnNCT00737763Phase 2
- A Study to Evaluate Efalizumab Compared With Cyclosporine As an Immunosuppressant Regimen in De Novo Renal TransplantationWithdrawnNCT00729768Phase 2/3
- Study of Efalizumab Combined With Intravitreal Ranibizumab in the Treatment of Age-Related Macular DegenerationWithdrawnNCT00726466Phase 1
- Combining Acitretin and Efalizumab in the Therapy of Chronic Plaque PsoriasisStatus unknownNCT00707070Phase 4
- Combined aPproach to Treatment Using Ranibizumab and Efalizumab for Diabetic Macular Edema Study: The CAPTURE DME StudyWithdrawnNCT00676559Phase 1
- Prevention of Autoimmune Destruction and Rejection of Human Pancreatic Islets Following Transplantation for Insulin Dependent Diabetes MellitusCompletedNCT00501709Phase 1/2
- Efalizumab for Treatment of Patients With Moderate to Severe PsoriasisCompletedNCT00442650Phase 3
- A Study to Evaluate the Effects of Efalizumab on Immune Responses in Subjects With Moderate Plaque PsoriasisCompletedNCT00382512Phase 1
- A Study to Evaluate Efalizumab in Adults With Plaque Psoriasis, Including Those Who Are Receiving Concomitant Antipsoriatic TherapiesCompletedNCT00338143Phase 3
- A Study to Evaluate the Safety and Efficacy of Efalizumab in Adult Patients With Plaque Psoriasis Involving the Hands and/or FeetCompletedNCT00312026Phase 4
- Discoid Lupus Erythematosus of the Scalp and a Trial of Biologic Therapy With RaptivaWithdrawnNCT00308204Phase 2
- A Safety and Efficacy Study to Evaluate Efalizumab in Combination With UVB for Moderate to Severe PsoriasisCompletedNCT00302445Phase 4
- CLEAR Study: Clinical Experience Acquired With Raptiva StudyCompletedNCT00256139Phase 3
- Efalizumab for Moderate to Severe Atopic DermatitisCompletedNCT00226057Phase 1
- Efficacy and Safety of Efalizumab in the Treatment of Moderate-Severe Hydradenitis SuppurativaCompletedNCT00134134Phase 1
- Safety and Effectiveness of Efalizumab to Treat Oral Lichen PlanusCompletedNCT00133107Not applicable
- A Study to Evaluate Raptiva in Adults With Moderate to Severe Plaque Psoriasis Who Are Candidates for Systemic TherapyCompletedNCT00109317Phase 3
- A Study to Evaluate Raptiva in Adults With Plaque Psoriasis Previously Enrolled in Study ACD2390gCompletedNCT00109252Phase 3
- A Study to Evaluate Raptiva in Combination With Topical Psoriasis TherapiesCompletedNCT00096980Phase 4
- A Study to Evaluate the Safety of Raptiva in Adults With Plaque Psoriasis Previously Enrolled in Study ACD2600gCompletedNCT00096603Phase 3
- Safety, Efficacy and Pharmacokinetics of an Antibody for Psoriatic ArthritisCompletedNCT00051662Phase 1
- Safety and Efficacy of a Monoclonal Antibody for Treatment of Rheumatoid Arthritis.CompletedNCT00034203Phase 2